Kevin Harrod, Ph.D.

Home
Research & Reports
About Our Research
Previously Funded Researchers
Kevin Harrod, PhD

Research Project:
Novel SARS-CoV-2 antivirals targeting viral encoded ion channels

Grant Awarded:

COVID-19 Respiratory Virus Research Award

Research Topic:

combination therapies experimental therapeutics

Research Disease:

COVID-19

Despite the rapid deployment of vaccines that offer protective immunity, immunizations will not eradicate SARS-CoV-2, and break through infections will occur. Thus, therapeutic interventions and particularly antivirals will be critical in the postimmunization era of COVID-19. This application will use a high throughput drug screening platform to identify and repurpose already FDA approved drugs that may interfere with normal viral replication and could be used to blunt viral infections of the lung.

Page last updated: June 7, 2024

Join the Patient & Caregiver Network

How to Help People Quit

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Register for a LUNG FORCE Walk

Double Your Gift

Kevin Harrod, PhD

2X Your Lifesaving Impact

Make a Donation

Become a Lung Health Insider

Select Your Location

Change Language

Lung HelpLine

1-800-LUNG-USA